Stereotactic body radiotherapy: A critical review for nonradiation oncologists

Stereotactic body radiotherapy (SBRT) involves the treatment of extracranial primary tumors or metastases with a few, high doses of ionizing radiation. In SBRT, tumor kill is maximized and dose to surrounding tissue is minimized, by precise and accurate delivery of multiple radiation beams to the target. This is particularly challenging, because extracranial lesions often move with respiration and are irregular in shape, requiring careful treatment planning and continual management of this motion and patient position during irradiation. This review presents the rationale, process workflow, and technology for the safe and effective administration of SBRT, as well as the indications, outcome, and limitations for this technique in the treatment of lung cancer, liver cancer, and metastatic disease. Cancer 2014;120:942–954. © 2013 American Cancer Society.

[1]  R. Weichselbaum,et al.  Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma , 2013, American journal of clinical oncology.

[2]  RobertI Miller,et al.  American Society for Radiation Oncology (ASTRO) 2012 Workforce Study: the radiation oncologists' and residents' perspectives. , 2013, International journal of radiation oncology, biology, physics.

[3]  D. Sher,et al.  Cost‐effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer , 2013, Cancer.

[4]  F. Yin,et al.  Radiotherapy and radiosurgery for tumors of the central nervous system. , 2013, Surgical oncology clinics of North America.

[5]  T. Showalter,et al.  Pushing the limits of radiation therapy for prostate cancer: where do we go next? , 2013, Seminars in oncology.

[6]  William Small,et al.  Perez & Brady's Principles and Practice of Radiation Oncology , 2013 .

[7]  Zahra Kassam,et al.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. Stief,et al.  Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer. , 2013, Urologic oncology.

[9]  S. T. Astner,et al.  Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy , 2013, Strahlentherapie und Onkologie.

[10]  D. Schaal,et al.  Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Cost-Effectiveness Results , 2013, Front. Oncol..

[11]  P. Bondiau,et al.  Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer. , 2013, International journal of radiation oncology, biology, physics.

[12]  S. Demaria,et al.  Combining radiotherapy and cancer immunotherapy: a paradigm shift. , 2013, Journal of the National Cancer Institute.

[13]  Oleksiy Karpenko,et al.  Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs , 2012, PloS one.

[14]  P. Lambin,et al.  Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450) , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  P. Okunieff,et al.  Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. , 2012, International journal of radiation oncology, biology, physics.

[16]  S. Perkins,et al.  Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma , 2012, Cancer.

[17]  Y. Lotan,et al.  Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer. , 2012, Journal of oncology practice.

[18]  Jan-Jakob Sonke,et al.  Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179. , 2012, Medical physics.

[19]  P. Brown,et al.  Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. , 2012, The Lancet. Oncology.

[20]  Aaron Ward,et al.  Radiographic changes after lung stereotactic ablative radiotherapy (SABR)--can we distinguish recurrence from fibrosis? A systematic review of the literature. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Michael Lock,et al.  Radiotherapy for liver metastases: a review of evidence. , 2012, International journal of radiation oncology, biology, physics.

[22]  R. Orecchia,et al.  Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. , 2012, International journal of radiation oncology, biology, physics.

[23]  R. Weichselbaum,et al.  Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  Timothy D. Solberg,et al.  Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: Executive summary , 2012, Practical radiation oncology.

[25]  P. Parikh,et al.  Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[26]  Cynthia S. Johnson,et al.  Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[27]  J. Ledermann,et al.  Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  Joe Y. Chang,et al.  Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. , 2011, International journal of radiation oncology, biology, physics.

[29]  Thierry Gevaert,et al.  Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial. , 2011, International journal of radiation oncology, biology, physics.

[30]  A. Garg,et al.  Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy , 2011, Cancer.

[31]  J. Bradley,et al.  Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. , 2011, European journal of radiology.

[32]  P. Okunieff,et al.  Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer , 2011, Radiation oncology.

[33]  Matthias Guckenberger,et al.  kV Cone-Beam CT-Based IGRT , 2011, Strahlentherapie und Onkologie.

[34]  D. Heron,et al.  Efficacy and cost-effectiveness analysis of external beam and stereotactic body radiation therapy in the treatment of spine metastases: a matched-pair analysis. , 2011, Journal of neurosurgery. Spine.

[35]  P. Weatherall,et al.  Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases , 2011, Annals of Surgical Oncology.

[36]  E. Mendel,et al.  Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. , 2011, International journal of radiation oncology, biology, physics.

[37]  L. Masi,et al.  Efficacy of Eradicative Radiotherapy for Limited Nodal Metastases Detected with Choline PET Scan in Prostate Cancer Patients , 2011, Tumori.

[38]  C. Reddy,et al.  Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. , 2010, International journal of radiation oncology, biology, physics.

[39]  L. Constine,et al.  Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. , 2010, International journal of radiation oncology, biology, physics.

[40]  B. Kavanagh,et al.  Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control , 2010, Radiation oncology.

[41]  A. Koong,et al.  Stereotactic Body Radiotherapy for Colorectal Liver Metastases: A Pooled Analysis , 2010 .

[42]  A. Koong,et al.  Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. , 2010, International journal of radiation oncology, biology, physics.

[43]  T. Lacornerie,et al.  Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary Results , 2010, Technology in cancer research & treatment.

[44]  H. Jang,et al.  Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer , 2010, BMC Cancer.

[45]  Dong Han Lee,et al.  Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma , 2010, Journal of surgical oncology.

[46]  E. B. Butler,et al.  Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. , 2010, Discovery medicine.

[47]  M. Schell,et al.  Stereotactic body radiation therapy: the report of AAPM Task Group 101. , 2010, Medical physics.

[48]  Y. Yamada,et al.  Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. , 2010, Journal of neurosurgery. Spine.

[49]  Lijun Ma,et al.  Spinal cord tolerance for stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[50]  M. Gönen,et al.  Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. , 2010, Journal of the American College of Surgeons.

[51]  R. Jain,et al.  Radiosurgical decompression of metastatic epidural compression , 2010, Cancer.

[52]  Umberto Ricardi,et al.  Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. , 2010, Lung cancer.

[53]  Mark K Buyyounouski,et al.  Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. , 2010, International journal of radiation oncology, biology, physics.

[54]  S. Perkins,et al.  Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[55]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[56]  P. Levendag,et al.  Stereotactic body radiation therapy for colorectal liver metastases , 2010, The British journal of surgery.

[57]  Randall K Ten Haken,et al.  Guest editor's introduction to QUANTEC: a users guide. , 2010, International journal of radiation oncology, biology, physics.

[58]  Ke Sheng,et al.  Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[59]  T. Schultheiss,et al.  Radiation dose-volume effects in the spinal cord. , 2010, International journal of radiation oncology, biology, physics.

[60]  Peter A S Johnstone,et al.  Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[61]  Lech Papiez,et al.  Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. , 2009, International journal of radiation oncology, biology, physics.

[62]  M. Bilsky,et al.  Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  P. Gerszten,et al.  Radiotherapy and Radiosurgery for Metastatic Spine Disease: What Are the Options, Indications, and Outcomes? , 2009, Spine.

[64]  Fang-Fang Yin,et al.  Task Group 142 report: quality assurance of medical accelerators. , 2009, Medical physics.

[65]  A. Bezjak,et al.  Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[66]  P. Francescon,et al.  Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results. , 2009, Anticancer research.

[67]  D. Sargent,et al.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  Jan Nyman,et al.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  Colin G Orton,et al.  The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2009, Medical physics.

[70]  Jan Nyman,et al.  Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[71]  A. Muhs,et al.  Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy , 2009, Breast Cancer Research and Treatment.

[72]  G. Lockwood,et al.  Phase I study of individualized stereotactic body radiotherapy of liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  Dong Han Lee,et al.  Stereotactic Body Radiation Therapy Using Three Fractions for Isolated Lung Recurrence from Colorectal Cancer , 2009, Oncology.

[75]  F. Yin,et al.  Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions , 2009, Radiation oncology.

[76]  Kenneth E Rosenzweig,et al.  Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? , 2008, International journal of radiation oncology, biology, physics.

[77]  H. Jang,et al.  Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis , 2008, BMC Cancer.

[78]  Masahiro Hiraoka,et al.  Stereotactic body radiotherapy for oligometastatic lung tumors. , 2008, International journal of radiation oncology, biology, physics.

[79]  Lawrence B Marks,et al.  The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2008, Seminars in radiation oncology.

[80]  Lech Papiez,et al.  Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[81]  G. Bepler,et al.  Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  Maria Hawkins,et al.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  J. Galvin,et al.  Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[84]  Hiroki Shirato,et al.  STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .

[85]  M. Gonen,et al.  Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. , 2007, Journal of the American College of Surgeons.

[86]  M. Schell,et al.  Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. , 2007, International journal of radiation oncology, biology, physics.

[87]  J. Rock,et al.  Partial volume tolerance of the spinal cord and complications of single‐dose radiosurgery , 2007, Cancer.

[88]  R. Abrams,et al.  Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[89]  Lech Papiez,et al.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[90]  F. Yin,et al.  Postoperative Radiosurgery for Malignant Spinal Tumors , 2006, Neurosurgery.

[91]  S. Gallinger,et al.  Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. , 2006, Journal of the American College of Surgeons.

[92]  U. Haedinger,et al.  Stereotactic radiotherapy of primary liver cancer and hepatic metastases , 2006, Acta oncologica.

[93]  Peter C Levendag,et al.  Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study , 2006, Acta oncologica.

[94]  J. Petersen,et al.  Phase II study on stereotactic body radiotherapy of colorectal metastases , 2006, Acta oncologica.

[95]  Masahiro Hiraoka,et al.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[96]  P. Gerszten,et al.  Single‐fraction radiosurgery for the treatment of spinal breast metastases , 2005, Cancer.

[97]  P. Gerszten,et al.  Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. , 2005, Journal of neurosurgery. Spine.

[98]  J. Petersen,et al.  Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer , 2005 .

[99]  Sten Nilsson,et al.  Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[100]  Mohammed Mohiuddin,et al.  Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial , 2005, The Lancet.

[101]  Z. Fuks,et al.  Engaging the vascular component of the tumor response. , 2005, Cancer cell.

[102]  John H Suh,et al.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. , 2005, Journal of the National Cancer Institute.

[103]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[104]  Y. Takai,et al.  Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. , 2004, International journal of radiation oncology, biology, physics.

[105]  D P Berry,et al.  The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. , 2003, European journal of cancer.

[106]  Jürgen Debus,et al.  Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[107]  M. Burt,et al.  Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. , 1999, Annals of surgery.

[108]  G. Tsumatori,et al.  Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients , 1998, Cancer.

[109]  H. Kogelnik Inauguration of radiotherapy as a new scientific speciality by Leopold Freund 100 years ago. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[110]  B. Nordlinger,et al.  Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.

[111]  O. S. Nielsen,et al.  Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group study of 255 patients , 1996, Cancer.

[112]  M. Burt,et al.  Resection of brain metastases from sarcoma , 1995, Annals of Surgical Oncology.

[113]  H. Scher,et al.  Surgical treatment of spinal cord compression in kidney cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[114]  A. Zinsmeister,et al.  Pulmonary resection of metastatic renal cell carcinoma. , 1983, Chest.

[115]  H. Coutard PRINCIPLES OF X RAY THERAPY OF MALIGNANT DISEASES , 1934 .

[116]  A. Sloan,et al.  ACR Appropriateness CriteriaMetastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis Expert Panel on Radiation Oncology-Bone Metastases: , 2015 .

[117]  H. Lam,et al.  Single fraction conventional external beam radiation therapy for bone metastases: a systematic review of randomised controlled trials. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[118]  J. Kao,et al.  Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases , 2013, Targeted Oncology.

[119]  S. Yoo,et al.  Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. , 2012, International journal of radiation oncology, biology, physics.

[120]  S. Ryu,et al.  ACR Appropriateness Criteria® non-spine bone metastases. , 2012, Journal of palliative medicine.

[121]  D. Heron,et al.  Stereotactic body radiation therapy for adrenal metastases: a retrospective review of a noninvasive therapeutic strategy. , 2011, Future oncology.

[122]  W. Franklin,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  C. Orton,et al.  Point/Counterpoint. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2009, Medical physics.

[124]  Frcsc Paul D. Greig MD,et al.  Survival After Hepatic Resection for Colorectal Metastases: A 10-Year Experience , 2006, Annals of Surgical Oncology.

[125]  J. Debus,et al.  Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial. , 2004, Frontiers of radiation therapy and oncology.

[126]  J. Fleshman,et al.  Liver resection for colorectal metastases. , 2004, Annals of the Royal College of Surgeons of England.

[127]  J. Rock,et al.  Patterns of failure after single-dose radiosurgery for spinal metastasis. , 2004, Journal of neurosurgery.

[128]  Daniel Normolle,et al.  Analysis of radiation-induced liver disease using the Lyman NTCP model. , 2002, International journal of radiation oncology, biology, physics.

[129]  I. Lax,et al.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. , 1995, Acta oncologica.

[130]  M. Rotman,et al.  Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. , 1993, International journal of radiation oncology, biology, physics.

[131]  S. A. Wilson,et al.  Disorders of motility and muscle tone with special reference to the corpus striatum , 1925 .

[132]  S. Richardson,et al.  Biij Biomedical Imaging and Intervention Journal the Treatment of Primary and Metastatic Renal Cell Carcinoma (rcc) with Image-guided Stereotactic Body Radiation Therapy (sbrt) , 2022 .